Mr. Flickinger has held sales roles at Medtronic, NuVasive and Surgalign.
“As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients,” Mr. Flickinger said in a Sept. 27 press release. “I’m looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
